Lessons Learned from the Clinical Development and Market Authorization of Glybera
Human Gene Therapy Clinical Development · 2013-06 · 24 (2) · 55-64
DOI: 10.1089/humc.2013.087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy Clinical Development, 2013-06. Verfasst von Laura M Bryant und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NEI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroscience Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA.
Förderung
- NICHD NIH HHS
- NEI NIH HHS
- NIDDK NIH HHS
- PHS HHS
- NHLBI NIH HHS
Zitieren
APA
Bryant, L. M., Christopher, D. M., Giles, A. R., Hinderer, C., Rodriguez, J. L., Smith, J. B., Traxler, E. A., Tycko, J., Wojno, A. P., & Wilson, J. M. (2013). Lessons Learned from the Clinical Development and Market Authorization of Glybera. Human Gene Therapy Clinical Development, 24(2), 55-64. https://doi.org/10.1089/humc.2013.087
Vancouver
Bryant LM, Christopher DM, Giles AR, Hinderer C, Rodriguez JL, Smith JB, et al. Lessons Learned from the Clinical Development and Market Authorization of Glybera. Human Gene Therapy Clinical Development. 2013;24(2):55-64. doi:10.1089/humc.2013.087
BibTeX
@article{Bryant2013,
author = {Bryant, Laura M and Christopher, Devin M and Giles, April R and Hinderer, Christian and Rodriguez, Jesse L and Smith, Jenessa B and Traxler, Elizabeth A and Tycko, Josh and Wojno, Adam P and Wilson, James M},
title = {Lessons Learned from the Clinical Development and Market Authorization of Glybera},
journal = {Human Gene Therapy Clinical Development},
year = {2013},
volume = {24},
number = {2},
pages = {55--64},
doi = {10.1089/humc.2013.087}
}
EUVIMED